Sale!

FECH Gene Protoporphyria Erythropoietic Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FECH Gene Protoporphyria Erythropoietic Type 1 Genetic Test is a specialized diagnostic tool used to detect mutations in the FECH gene, which are responsible for Erythropoietic Protoporphyria (EPP) Type 1. EPP is a rare genetic condition characterized by a deficiency in the enzyme ferrochelatase, leading to an accumulation of protoporphyrin in the blood, skin, and liver, causing severe photosensitivity, skin damage, and possibly liver complications. The test involves analyzing the patient’s DNA to identify any genetic abnormalities in the FECH gene that may indicate the presence of EPP Type 1.

Conducted at DNA Labs UAE, a leading facility in genetic and genomic testing, this test provides crucial information for the accurate diagnosis and management of EPP. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to perform this advanced genetic analysis. Identifying the specific mutation within the FECH gene can help in understanding the severity of the condition, guiding treatment options, and offering genetic counseling for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FECH Gene Protoporphyria erythropoietic type 1 Genetic Test

At DNA Labs UAE, we offer the FECH Gene Protoporphyria erythropoietic type 1 Genetic Test at a cost of 4400.0 AED.

Test Details

The FECH gene protoporphyria, erythropoietic type 1 NGS genetic test is a type of genetic test that utilizes next-generation sequencing (NGS) technology to analyze the FECH gene for mutations associated with erythropoietic protoporphyria (EPP) type 1.

Erythropoietic protoporphyria is a rare genetic disorder characterized by the accumulation of protoporphyrin IX in the body, leading to photosensitivity and skin symptoms upon exposure to sunlight. EPP type 1 is caused by mutations in the FECH gene, which provides instructions for producing the enzyme ferrochelatase involved in the production of heme.

The NGS genetic test for FECH gene protoporphyria aims to identify any mutations or genetic variations in the FECH gene that may contribute to the development of EPP type 1. This test involves sequencing the entire coding region of the FECH gene to detect any changes in the DNA sequence.

By identifying specific mutations or genetic variations in the FECH gene, this NGS genetic test can help in the diagnosis of EPP type 1 and provide information for genetic counseling and management of the condition. It can also be used for carrier testing and prenatal testing for individuals with a family history of EPP type 1.

It is important to note that the interpretation of NGS genetic test results should be done by a qualified healthcare professional who specializes in genetics, as the presence of a mutation does not necessarily guarantee the development of the condition. Additionally, genetic testing may have limitations, and negative results do not completely rule out the possibility of having or developing the condition.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the FECH Gene Protoporphyria erythropoietic type 1 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with FECH Gene Protoporphyria, erythropoietic type 1 NGS Genetic DNA Test gene FECH.

Test Name FECH Gene Protoporphyria erythropoietic type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FECH Gene Protoporphyria, erythropoietic type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FECH Gene Protoporphyria, erythropoietic type 1 NGS Genetic DNA Test gene FECH
Test Details

FECH gene protoporphyria, erythropoietic type 1 NGS genetic test is a type of genetic test that utilizes next-generation sequencing (NGS) technology to analyze the FECH gene for mutations associated with erythropoietic protoporphyria (EPP) type 1.

Erythropoietic protoporphyria is a rare genetic disorder characterized by the accumulation of protoporphyrin IX in the body, leading to photosensitivity and skin symptoms upon exposure to sunlight. EPP type 1 is caused by mutations in the FECH gene, which provides instructions for producing the enzyme ferrochelatase involved in the production of heme.

The NGS genetic test for FECH gene protoporphyria aims to identify any mutations or genetic variations in the FECH gene that may contribute to the development of EPP type 1. This test involves sequencing the entire coding region of the FECH gene to detect any changes in the DNA sequence.

By identifying specific mutations or genetic variations in the FECH gene, this NGS genetic test can help in the diagnosis of EPP type 1 and provide information for genetic counseling and management of the condition. It can also be used for carrier testing and prenatal testing for individuals with a family history of EPP type 1.

It is important to note that the interpretation of NGS genetic test results should be done by a qualified healthcare professional who specializes in genetics, as the presence of a mutation does not necessarily guarantee the development of the condition. Additionally, genetic testing may have limitations, and negative results do not completely rule out the possibility of having or developing the condition.